Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Biogen Idec has reached an agreement with Carl Icahn, naming one of Icahn’s nominees to its board. In exchange, the activist investor dropped a threatened proxy fight. The biopharmaceutical firm appointed Eric K. Rowinsky and Stephen A. Sherwin to the board to replace outgoing members James C. Mullen and Bruce R. Ross. Rowinsky is one of three people Icahn has been attempting to put on the board since early last year in an effort to sell or break up Biogen. “The nominees who will replace Messrs. Mullen and Ross are extremely qualified and I believe will add great value to Biogen,” Icahn said in a statement./p>
This article has been sent to the following recipient: